Clinical trials
Phase 2 Attention Deficit Disorder with Hyperactivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
127 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 11 |
| 2006 | 9 |
| 2007 | 12 |
| 2008 | 10 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Unknown status | 12 |
| Terminated | 9 |
| Recruiting | 7 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie (prior sponsor, Abbott) | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| Shire | 5 |
| New York State Psychiatric Institute | 4 |
| Supernus Pharmaceuticals, Inc. | 4 |
| Abbott | 3 |
| Alcobra Ltd. | 3 |
| Eli Lilly and Company | 3 |
| Pfizer | 3 |
| Aevi Genomic Medicine, LLC, a Cerecor company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 127 |
| Spasm | 7 |
| Substance-Related Disorders | 5 |
| Cocaine-Related Disorders | 4 |
| Autism Spectrum Disorder | 3 |
| Neurodevelopmental Disorders | 3 |
| Anxiety Disorders | 2 |
| Attention Deficit and Disruptive Behavior Disorders | 2 |
| Autistic Disorder | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.
27 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.